These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17614126)

  • 1. Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B.
    Ferrandina G; Scambia G; Legge F; Petrillo M; Salutari V
    Gynecol Oncol; 2007 Oct; 107(1):154-6. PubMed ID: 17614126
    [No Abstract]   [Full Text] [Related]  

  • 2. [The place of lumo-aortic and pelvic lymph node dissection in the treatment of ovarian cancer].
    Salet-Lizée D; Alsary S
    J Chir (Paris); 2008 Dec; 145 Spec no. 4():12S45-12S49. PubMed ID: 19194358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of lymph node metastasis in ovarian cancer].
    Tolino A; Di Serio C; Borruto Caracciolo G; Bartiromo F; Cinque SM
    Minerva Ginecol; 1987; 39(1-2):31-6. PubMed ID: 3574745
    [No Abstract]   [Full Text] [Related]  

  • 4. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer.
    Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB
    Acta Obstet Gynecol Scand; 2008; 87(11):1136-42. PubMed ID: 18951217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical management of mesenteric lymph node metastasis in patients undergoing rectosigmoid colectomy for locally advanced ovarian carcinoma.
    Salani R; Diaz-Montes T; Giuntoli RL; Bristow RE
    Ann Surg Oncol; 2007 Dec; 14(12):3552-7. PubMed ID: 17896149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of ovarian cancer with pelvic and paraaortic lymph node metastasis].
    Ebina Y; Yamamoto R; Sakuragi N
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():565-9. PubMed ID: 15535309
    [No Abstract]   [Full Text] [Related]  

  • 7. [Status of lymph node excision in surgical treatment of ovarian cancer].
    Lahousen M; Stettner H; Pickel H
    Gynakol Rundsch; 1990; 30 Suppl 1():30-3. PubMed ID: 2079294
    [No Abstract]   [Full Text] [Related]  

  • 8. Controversies in the management of ovarian cancer--pros and cons for lymph node dissection in ovarian cancer.
    Camara O; Sehouli J
    Anticancer Res; 2009 Jul; 29(7):2837-43. PubMed ID: 19596971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node ratio: role in the staging of node-positive colon cancer.
    Wang J; Hassett JM; Dayton MT; Kulaylat MN
    Ann Surg Oncol; 2008 Jun; 15(6):1600-8. PubMed ID: 18327530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer.
    Fotiou S; Aliki T; Petros Z; Ioanna S; Konstantinos V; Vasiliki M; George C
    Gynecol Oncol; 2009 Aug; 114(2):178-82. PubMed ID: 19450872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer complicating pregnancy: implications of laparoscopic lymphadenectomy.
    Alouini S; Rida K; Mathevet P
    Gynecol Oncol; 2008 Mar; 108(3):472-7. PubMed ID: 18201752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on lymphadenectomy in early and advanced ovarian cancer.
    Angioli R; Plotti F; Palaia I; Calcagno M; Montera R; Cafà EV; Sereni MI; Panici PB
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):34-9. PubMed ID: 18197003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axillary lymph node metastasis from serous ovarian cancer: a case report and review of the literature.
    Aydin C; Unalp HR; Baloğlu A; Inci AG; Yiğit S; Yavuzcan A
    Arch Gynecol Obstet; 2009 Feb; 279(2):203-7. PubMed ID: 18470522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EORTC-GCG process quality indicators for ovarian cancer surgery.
    Verleye L; Ottevanger PB; van der Graaf W; Reed NS; Vergote I;
    Eur J Cancer; 2009 Mar; 45(4):517-26. PubMed ID: 19013789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].
    Zhang GQ; Han F; Gao SL; A DL; Pang ZL
    Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
    Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lymph node metastasis from ovarian cancer in the 1st stage in relation to the histological type of the tumor].
    Baratta A; Guidi G; Bassi G; Bertoli C
    Minerva Ginecol; 1983 Jun; 35(6):401-4. PubMed ID: 6621922
    [No Abstract]   [Full Text] [Related]  

  • 18. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes.
    Hoekstra AV; Kim RJ; Small W; Rademaker AW; Helenowski IB; Singh DK; Schink JC; Lurain JR
    Gynecol Oncol; 2009 Aug; 114(2):273-8. PubMed ID: 19428094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer.
    Fujimoto T; Nanjyo H; Nakamura A; Yokoyama Y; Takano T; Shoji T; Nakahara K; Yamada H; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
    Gynecol Oncol; 2007 Nov; 107(2):253-9. PubMed ID: 17640720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thoracoscopic lobectomy with systemic lymph node dissection for lymph node positive non-small cell lung cancer--is thoracoscopic lymph node dissection feasible?
    Shiraishi T; Hiratsuka M; Yoshinaga Y; Yamamoto S; Iwasaki A; Shirakusa T
    Thorac Cardiovasc Surg; 2008 Apr; 56(3):162-6. PubMed ID: 18365976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.